Association of gene expression with outcomes with everolimus as post-VEGF inhibitor therapy for renal cell carcinoma (RCC).
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e16554
Abstract: e16554Background: The use of everolimus (E) monotherapy to treat RCC has diminished due to the approvals of new agents. We hypothesized that gene expression associated with benefit may provide the ... read more here.
Keywords: association gene; rcc; expression outcomes; gene expression ... See more keywords